DalsnaFinance › IPOs › Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. completed its initial public offering on NASDAQ on October 29, 2021, pricing at $20.00 a share.
| Ticker | TRDA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 29, 2021 |
| Offering price | $20.00 |
| Shares offered | 9,075,000 |
| Total raised | $182M |
Entrada Therapeutics, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.